CTOs on the Move

Health Research

www.hrinet.org

 
Health Research is a Rensselaer, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.hrinet.org
  • 1 University Pl
    Rensselaer, NY USA 12144
  • Phone: 518.431.1200

Executives

Name Title Contact Details

Similar Companies

AllMed

AllMed Healthcare Management is a utilization management and independent review organization providing comprehensive nurse and physician review solutions to payer and provider organizations nationwide. Our clients include leading health plans, medical management organizations, TPAs, disability carriers, hospital groups and ambulatory surgery centers. Services are deployed through PeerPoint, AllMed`s state-of-the-art medical review portal.

Specialty Medical Sales

Specialty Medical Sales is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SciTec

SciTec is a company that provides cutting edge advancements for defense, security, and civil affairs. Their team is committed to delivering advanced sensor systems, data processing algorithms, and testing equipment for defense, national security, and c...

Anchor Products Co

Anchor Products Co is a Addison, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PolyNovo Limited

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.